Managementul și inversarea anticoagulării

Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (se deschide o fereastră nouă)

Coccolini F, Shander A, Ceresoli M, Moore E, Tian B, Parini D, Sartelli M, Sakakushev B, Doklestich K, Abu-Zidan F, Horer T, Shelat V, Hardcastle T, Bignami E, Kirkpatrick A, Weber D, Kryvoruchko I, Leppaniemi A, Tan E, Kessel B, Isik A, Cremonini C, Forfori F, Ghiadoni L, Chiarugi M, Ball C, Ottolino P, Hecker A, Mariani D, Melai E, Malbrain M, Agostini V, Podda M, Picetti E, Kluger Y, Rizoli S, Litvin A, Maier R, Beka SG, De Simone B, Bala M, Perez AM, Ordonez C, Bodnaruk Z, Cui Y, Calatayud AP, de Angelis N, Amico F, Pikoulis E, Damaskos D, Coimbra R, Chirica M, Biffl WL, Catena F

Sursă‎: World J Emerg Surg 2024;19(1):26.

Index‎: PubMed 39010099

DOI‎: 10.1186/s13017-024-00554-7

https://pubmed.ncbi.nlm.nih.gov/39010099/ (se deschide o fereastră nouă)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (se deschide o fereastră nouă)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Sursă‎: Lancet 2015;385(9982):2077-87.

Index‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (se deschide o fereastră nouă)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (se deschide o fereastră nouă)

Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J.

Sursă‎: Am J Hematol 2012;87 Suppl 1:S141-5.

Index‎: PubMed 22473649

DOI‎: 10.1002/ajh.23202

https://www.ncbi.nlm.nih.gov/pubmed/22473649 (se deschide o fereastră nouă)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (se deschide o fereastră nouă)

Levi M, Eerenberg E, Kamphuisen PW.

Sursă‎: J Thromb Haemost 2011;9(9):1705-12.

Index‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (se deschide o fereastră nouă)

Emergency reversal of warfarin anticoagulation. (se deschide o fereastră nouă)

Lin Y, Callum J.

Sursă‎: CMAJ 2010;182(18):2004.

Index‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (se deschide o fereastră nouă)

Management of anticoagulation agents in trauma patients. (se deschide o fereastră nouă)

McCoy CC, Lawson JH, Shapiro ML.

Sursă‎: Clin Lab Med 2014;34(3):563-74.

Index‎: PubMed 25168942

DOI‎: 10.1016/j.cll.2014.06.013

https://www.ncbi.nlm.nih.gov/pubmed/25168942 (se deschide o fereastră nouă)

Idarucizumab for dabigatran reversal - full cohort analysis. (se deschide o fereastră nouă)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Sursă‎: N Engl J Med 2017;377(5):431-41.

Index‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (se deschide o fereastră nouă)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (se deschide o fereastră nouă)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Sursă‎: Anesth Analg 2011;113(4):703-10.

Index‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (se deschide o fereastră nouă)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (se deschide o fereastră nouă)

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

Sursă‎: World Neurosurg 2014;81(1):110-5.

Index‎: PubMed 23220122

DOI‎: 10.1016/j.wneu.2012.12.002

https://www.ncbi.nlm.nih.gov/pubmed/23220122 (se deschide o fereastră nouă)

TRAUMATOLOGIE ŞI MEDICINĂ DE URGENŢĂ

Managementul și inversarea anticoagulării

Română

Managementul și inversarea anticoagulării

https://assetsnffrgf-a.akamaihd.net/assets/ct/e8b2bff3b7/images/syn_placeholder_sqr.png

Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (se deschide o fereastră nouă)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (se deschide o fereastră nouă)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (se deschide o fereastră nouă)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (se deschide o fereastră nouă)

Emergency reversal of warfarin anticoagulation. (se deschide o fereastră nouă)

Management of anticoagulation agents in trauma patients. (se deschide o fereastră nouă)

Idarucizumab for dabigatran reversal - full cohort analysis. (se deschide o fereastră nouă)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (se deschide o fereastră nouă)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (se deschide o fereastră nouă)

Comitete de legătură cu spitalele (CLS)

Materiale medicale informative

Materiale video

Managementul și inversarea anticoagulării

Selectaţi limba dorită

Partajează